Yüklüyor......
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma
Chondrosarcoma is the most common bone sarcoma in adults. Conventional chondrosarcoma, the commonest histological subtype, is largely resistant to anthracycline-based chemotherapy. There have been anecdotal reports of durable clinical benefit with antiangiogenic agents in this disease. A retrospecti...
Kaydedildi:
| Yayımlandı: | Med Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574947/ https://ncbi.nlm.nih.gov/pubmed/28852958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-017-1030-2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|